Loading…
Loading…
PHBI does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for PHBI and 80,000+ other tickers.
See exactly how PHBI's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for PHBI and 80,000+ other tickers.
Pharmagreen Biotech Inc. is a biotechnology solutions provider primarily engaged in cultivating young plant stock for the medical cannabis and CBD hemp industries. Established in 2007, the company operates from its base in Coquitlam, Canada.
CARSON CITY, Nev., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Pharmagreen Biotech, Inc. (OTC PINKS: PHBI) ("Pharmagreen" or the "Company") is thrilled to highlight the significant revenue potential from its latest project under development. During a special session on Creative Spaces, hosted on X on Monday, October 7, 2024, CEO Peter Wojcik shared exciting insights into the company's business advancements and growth strategies.
CARSON CITY, NV, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Pharmagreen Biotech, Inc. (OTC PINKS: PHBI) ("Pharmagreen" or the "Company") is pleased to announce the continued advancement of its business development efforts on a significant project in collaboration with a foreign government. Considerable progress has been made, and the Company is optimistic about the wide-ranging benefits this initiative will bring to all involved parties.
CARSON CITY, NV / ACCESSWIRE / January 24, 2024 / Pharmagreen Biotech, Inc., (OTC PINK:PHBI), "Pharmagreen" or the "Company" is pleased to announce the signing of a supply agreement with SierraSil® Health Inc., a manufacturer specializing in a proprietary natural hydrothermal mineral complex known as SierraSil®. This patented mineral complex, developed by SierraSil® Health Inc., adheres to rigorous standards is supported by two US patents and extensive clinical research.
Carson City, Nevada--(Newsfile Corp. - September 29, 2021) - Pharmagreen Biotech, Inc., (OTC Pink: PHBI), is pleased to update its shareholders on the company's Regulation A offering and ongoing progress with the California acquisition previously announced in a news release published on August 12, 2021. The SEC's notice of qualification with respect to the Reg A offering was issued on September 24, 2021. A portion of the proceeds from this offering will be used to...
Carson City, Nevada--(Newsfile Corp. - August 12, 2021) - Pharmagreen Biotech, Inc., (OTC Pink: PHBI), is pleased to update its shareholders on the company's developments and progress. Our business development has reached the next milestone with the signing of an MOU (Memorandum Of Understanding), on July 25, 2021, to acquire all the assets (includes property, structures and cannabis licences) and further develop a state of the art flowering greenhouse of approximately 12,000 sq ft...